Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecules and Cells is Scopus-indexed (Q2, CiteScore 7.2), WoS SCIE, DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 0219-1032Verify ISSN ↗1016-8478Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Molecular Biology | 135 / 414 | 67th | Q2 |
| Cell Biology | 106 / 289 | 63rd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q2, CiteScore 7.2.
Molecules and Cells is Q2 in Molecular Biology (rank 135 of 414) and Q2 in Cell Biology (rank 106 of 289), by CiteScore 2025.
Molecules and Cells is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.2, which places it in quartile Q2 at the 67th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.932, quartile Q1, with an H-index of 108.
The publisher lists an article processing charge of about US$2,500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Molecules and Cells is published by Elsevier B.V. Its print ISSN is 0219-1032 and its online ISSN is 1016-8478.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Molecules and Cells has an h-index of 117 and a 2-year mean of 6.82 citations per paper (OpenAlex). Its Scopus CiteScore is 7.2, quartile Q2. On 2-year citations it ranks #53 of 411 Scopus journals in Molecular Biology.
Molecules and Cells published 102 papers in 2025; its busiest recent year was 2024 with 117. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 85 research articles (2025–2026), authors are most often from South Korea (74.1%), China (9.6%) and United States (9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 27 retracted papers are recorded (6.7 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.